Company Registered in England & Wales No. 06373341
Consent to display content from Youtube
Consent to display content from Vimeo
Consent to display content from Google
Consent to display content from Spotify
Consent to display content from Sound
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Rachel has broad experience across industry and academia, spanning start up biotech to large scale CRO. Prior to Imagen Therapeutics she spent 8 years at the Sanger Institute. During this time she led her department in delivering world leading, large scale projects, including deriving 100s of human iPSCs (HipSci) and cancer organoids, and ran whole genome CRIPSR screen on cancer lines, organoids and iPCS. In the government response to the COVID pandemic, she was responsible for the urgent conversion of her cell biology lab to a COVID processing facility as part of the genomic surveillance initiative.
Rachel is passionate about project, process, resource and change management, including Lean methodology. It is the application of these skills and her understanding of how to build exceptional team culture that makes her a successful leader with a proven track record of building high performing teams.